Evaluation of the outcomes of vagal nerve stimulation in children with drug-refractory epilepsy in South Africa. [PDF]
Kibuuka E +3 more
europepmc +1 more source
Editorial: Invasive and non-invasive vagal nerve stimulation for the brain. [PDF]
Yu Y, Wang Y.
europepmc +1 more source
Schematic overview of the human microbiome and major microbiota‐derived metabolites across body sites, highlighting the gut–brain, gut–heart, and gut–kidney axes in host physiology and disease. ABSTRACT Background The human microbiome is a dynamic and diverse community of microorganisms that affects susceptibility to illness and promotes wellness ...
Awadh Alanazi
wiley +1 more source
Abstract Menstrual cycle tracking remains challenged by the limited physiological scope and inconsistent generalizability of existing wearable‐based approaches, which often rely on individual sensing modalities that incompletely capture the complexity of menstrual physiology.
Ejay Nsugbe, Georgianna Lin
wiley +1 more source
Role of physical exercise, vagal nerve stimulation, and vagotomy in inflammatory bowel disease. [PDF]
da Silva ACA +11 more
europepmc +1 more source
Abstract Objectives Pediatric acute pancreatitis (AP), Crohn's disease (CD), and irritable bowel syndrome (IBS) are associated with gut dysbiosis, but differences and similarities between conditions are unknown. We hypothesized that gut microbial ecology would differ across these disorders. Methods Stool was collected from 120 subjects (AP [n = 30], CD
Neha R. Santucci +9 more
wiley +1 more source
A pilot study of brain correlates of long-term treatment with transcutaneous vagal nerve stimulation in posttraumatic stress disorder. [PDF]
Bremner JD +10 more
europepmc +1 more source
The prospects for poststroke neural repair with vagal nerve stimulation. [PDF]
Ward N.
europepmc +1 more source
Transcutaneous Auricular Vagal Nerve Stimulation Against Fatigue Syndrome in Patients with Long COVID: Results of the Randomized, Placebo-Controlled Clinical Pilot Trial COVIVA. [PDF]
Gierthmuehlen M +3 more
europepmc +1 more source
Pregabalin Efficacy in Treatment of Chronic Neurogenic Cough
The use of neuromodulators for chronic cough has increased; however, the choice of medication, dosing regimen, and duration are still unclear. This longitudinal study of 95 adults taking pregabalin, 75 mg twice daily, for CNC demonstrated 78% improvement or resolution of cough, 17% unchanged, 1% worse cough, with a mean of 6 weeks of therapy, and only ...
Jacqui Allen +3 more
wiley +1 more source

